Just What The Market Needs

If Sanofi does indeed take over Genzyme that should give a nice boost to the market. The deal would be worth close to $20 billion in cash. A large chunk of that cash should find its way into other biotechnology stocks. In my opinion Gilead is a screaming buy right here, given their buyback and this possible takeover.

1 comment:

Anonymous said...

Dow is up 400 in 3 days.

The low Tuesday was 10007.

How much more before a pullback? 2-300?